在接受oclacitinib治疗的过敏性皮肤炎的狗中减少了抗菌药物的使用
Kennedy Mwacalimba1, Andrew Hillier2, Michele Rosenbaum2
1Zoetis Outcomes Research, Parsippany, NJ, United States.
Frontiers in veterinary science
|September 25, 2023
概括
奥克拉西替尼和葡萄糖皮质类药物减少了对过敏性皮肤炎和皮肤炎的狗的抗菌药物的使用. 奥克拉西替尼治疗也改善了生活质量,减少了整体治疗需求.
科学领域:
- 兽医皮肤病学 兽医皮肤病学
- 狗的健康 狗的健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有过敏性皮肤炎的狗经常会出现二次性皮肤和耳部感染.
- 热皮症是一种常见的并发症,需要抗微生物治疗.
- 的管理对于控制感染和改善狗的福祉至关重要.
研究的目的:
- 为了比较用oclacitinib或glucocorticoids治疗过敏性皮肤炎和皮肤炎的狗的抗菌药物的使用,与没有接受治疗的狗进行比较.
- 评估oclacitinib对抗微生物药物使用,并发疗法和过敏性皮肤炎犬的生命质量的长期影响.
主要方法:
- 在大型犬群中对抗微生物药物交易的回顾性分析.
- 一项前性研究,评估60天内的生活质量,治疗满意度和并发疗法.
- 不同的治疗方法之间的抗菌素使用和治疗结果的统计比较.
主要成果:
- 奥克拉西替尼和葡萄糖皮质体治疗与后续抗菌药物交易的几率降低有关.
- 奥克拉西替尼 (oclacitinib) 显著改善了主人和狗的生活质量得分.
- 奥克拉西替尼治疗导致同时治疗的治疗量大幅减少,包括全身性抗菌药物.
结论:
- 治疗,特别是用oclacitinib,可以减少对过敏性皮肤炎和皮肤炎的狗进行后续抗菌治疗的需要.
- 通过改善生活质量和减少对抗微生物药物的依赖,oclacitinib提供了一种有价值的治疗选择.
- 这些发现支持转向对犬类过敏性和相关感染的综合治疗策略的范式转变.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
326
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
326
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
289
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
289
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
186
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
186
Antiasthma Drugs: Leukotriene Modifiers
338
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
338
Antimicrobial Effectiveness
37
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
37
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144


